INCY
+$0
1,642 sh
BAKER BROS. ADVISORS LP
Director, 10% Owner · SEC CIK 1263508
Insider at
PRLD Prelude Therapeutics Inc
INCY INCYTE CORP
DNLI Denali Therapeutics Inc.
ACAD ACADIA PHARMACEUTICALS INC
KNSA Kiniksa Pharmaceuticals International, plc
ONC BeiGene, Ltd.
TCRX TScan Therapeutics, Inc.
REPL Replimune Group, Inc.
DBVT DBV Technologies S.A.
BCYC BICYCLE THERAPEUTICS PLC
KOD Kodiak Sciences Inc.
KYMR Kymera Therapeutics, Inc.
TRDA Entrada Therapeutics, Inc.
KALA KALA BIO, Inc.
CELC Celcuity Inc.
VTVT vTv Therapeutics Inc.
MDGL MADRIGAL PHARMACEUTICALS, INC.
IGMS IGM Biosciences, Inc.
IMCR Immunocore Holdings plc
Advertisement
Buy track record
How this insider's open-market purchases have performed70%
of buys now in profit
42 up · 18 down
Avg return since buy+12.3%
Median return+22.8%
Best trade+41.6%
Worst trade−29.6%
Buys scored60
Average return by holding period — separates good entry timing from riding one long winner
After 1 month
+14.9%
90% won · 60 trades
After 3 months
+37.8%
93% won · 60 trades
After 6 months
+11.8%
69% won · 58 trades
After 12 months
—
not elapsed yet
| Date | Company | 90d trend | Buy price | Value | ΔOwn | 1M | 3M | 6M | 12M | To date |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | KOD | $23 | $5M | +16% | +1.0% | −16.3% | — | — | +29.1% | |
| Dec 18, 2025 | KOD | $23 | $55M | +15% | +1.0% | −16.3% | — | — | +29.1% | |
| Dec 11, 2025 | KYMR | $86 | $14.38M | +31% | −16.8% | −7.2% | −5.5% | — | −1.8% | |
| Dec 11, 2025 | KYMR | $86 | $158.12M | +30% | −16.8% | −7.2% | −5.5% | — | −1.8% | |
| Nov 20, 2025 | TRDA | $9 | $11K | +0.3% | +15.8% | +23.1% | −34.1% | — | −29.6% | |
| Nov 20, 2025 | TRDA | $9 | $121.4K | +0.3% | +15.8% | +23.1% | −34.1% | — | −29.6% | |
| Nov 20, 2025 | TRDA | $9 | $10.8K | +0.3% | +15.8% | +23.1% | −34.1% | — | −29.6% | |
| Nov 20, 2025 | TRDA | $9 | $118.7K | +0.3% | +15.8% | +23.1% | −34.1% | — | −29.6% | |
| Nov 12, 2025 | TRDA | $8 | $56.6K | +2.0% | +38.3% | +34.8% | −11.1% | — | −19.4% | |
| Nov 12, 2025 | TRDA | $8 | $625.3K | +1.8% | +38.3% | +34.8% | −11.1% | — | −19.4% | |
| Nov 12, 2025 | TRDA | $8 | $8.3K | +0.3% | +38.3% | +34.8% | −11.1% | — | −19.4% | |
| Nov 12, 2025 | TRDA | $8 | $91.4K | +0.2% | +38.3% | +34.8% | −11.1% | — | −19.4% | |
| Nov 11, 2025 | TRDA | $7 | $7.8K | +0.3% | +40.4% | +43.8% | −9.1% | — | −16.1% | |
| Nov 11, 2025 | TRDA | $7 | $86.5K | +0.3% | +40.4% | +43.8% | −9.1% | — | −16.1% | |
| Nov 11, 2025 | TRDA | $8 | $21.1K | +0.8% | +40.4% | +43.8% | −9.1% | — | −16.1% | |
| Nov 11, 2025 | TRDA | $8 | $232.8K | +0.7% | +40.4% | +43.8% | −9.1% | — | −16.1% | |
| Nov 10, 2025 | TRDA | $7 | $16.6K | +0.6% | +45.9% | +49.0% | −3.6% | — | −11.0% | |
| Nov 10, 2025 | TRDA | $7 | $183K | +0.6% | +45.9% | +49.0% | −3.6% | — | −11.0% | |
| Nov 10, 2025 | TRDA | $7 | $1.9K | +0.1% | +45.9% | +49.0% | −3.6% | — | −11.0% | |
| Nov 10, 2025 | TRDA | $7 | $21.3K | +0.1% | +45.9% | +49.0% | −3.6% | — | −11.0% | |
| Sep 8, 2025 | CELC | $56 | $785.7K | +2.0% | −20.8% | +66.4% | +81.4% | — | +41.6% | |
| Sep 8, 2025 | CELC | $56 | $8.52M | +2.1% | −20.8% | +66.4% | +81.4% | — | +41.6% | |
| Sep 8, 2025 | CELC | $58 | $22.5K | +0.1% | −20.8% | +66.4% | +81.4% | — | +41.6% | |
| Sep 8, 2025 | CELC | $58 | $244.4K | +0.1% | −20.8% | +66.4% | +81.4% | — | +41.6% | |
| Aug 20, 2025 | MDGL | $380 | $182.6K | +0.2% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $380 | $1.98M | +0.3% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $381 | $67K | +0.1% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $381 | $730.7K | +0.1% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $381 | $332.7K | +0.4% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $381 | $3.61M | +0.5% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $382 | $40.1K | +0.1% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $382 | $434.3K | +0.1% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $383 | $100.3K | +0.1% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $383 | $1.09M | +0.1% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $384 | $143.2K | +0.2% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $384 | $1.55M | +0.2% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $385 | $480.6K | +0.6% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $385 | $5.22M | +0.7% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $387 | $158.3K | +0.2% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $387 | $1.72M | +0.2% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $389 | $13.2K | — | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $389 | $142.4K | — | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $390 | $90.1K | +0.1% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $390 | $977.1K | +0.1% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $392 | $338.1K | +0.4% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 20, 2025 | MDGL | $392 | $3.67M | +0.5% | +12.4% | +38.4% | +11.1% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $373 | $917.3K | +1.3% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $373 | $9.96M | +1.4% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $374 | $252.7K | +0.3% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $374 | $2.74M | +0.4% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $354 | $62.6K | +0.1% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $354 | $680.5K | +0.1% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $355 | $29.8K | — | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $355 | $325.2K | +0.1% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $357 | $273.8K | +0.4% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $357 | $2.97M | +0.5% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $358 | $81.7K | +0.1% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $358 | $885.5K | +0.1% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $359 | $281.8K | +0.4% | +12.6% | +42.8% | +25.6% | — | +22.8% | |
| Aug 18, 2025 | MDGL | $359 | $3.06M | +0.5% | +12.6% | +42.8% | +25.6% | — | +22.8% |
How this is calculated. We score only open-market purchases (SEC code
P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 60 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$334.45M
80 trades
Open-market sells
$1.19M
6 trades
Net flow
+$333.26M
Net buying
Total filings
105
transactions shown
Full transaction history
All Form 4 activity across every company, newest firstDNLI
+$0
6,408 sh
ACAD
+$0
18,622 sh
KNSA
+$0
6,078 sh
ONC
−$65.4K
2,743 sh @ $24
Advertisement
ONC
−$65.6K
2,756 sh @ $24
INCY
+$1.27M
15,000 sh @ $85
INCY
+$0
421 sh
BCYC
+$0
19,000 sh
INCY
+$0
328 sh
KOD
Baker Bros. Advisors Lp, KOD's 10% owner, spent $5M of their own money on 217,428 shares at $23, growing their stake 16%.
+$5M
217,428 sh @ $23
KOD
Baker Bros. Advisors Lp, KOD's 10% owner, spent $55M of their own money on 2.39M shares at $23, growing their stake 15%.
+$55M
2.39M sh @ $23
KYMR
Baker Bros. Advisors Lp, KYMR's 10% owner, spent $14.38M of their own money on 167,192 shares at $86, growing their stake 31%.
+$14.38M
167,192 sh @ $86
KYMR
Baker Bros. Advisors Lp, KYMR's 10% owner, spent $158.12M of their own money on 1.84M shares at $86, growing their stake 30%.
+$158.12M
1.84M sh @ $86
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $11K of their own money on 1,213 shares at $9.
+$11K
1,213 sh @ $9
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $121.4K of their own money on 13,386 shares at $9.
+$121.4K
13,386 sh @ $9
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $10.8K of their own money on 1,186 shares at $9.
+$10.8K
1,186 sh @ $9
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $118.7K of their own money on 13,082 shares at $9.
+$118.7K
13,082 sh @ $9
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $56.6K of their own money on 7,321 shares at $8, growing their stake 2%.
+$56.6K
7,321 sh @ $8
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $625.3K of their own money on 80,881 shares at $8, growing their stake 2%.
+$625.3K
80,881 sh @ $8
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $8.3K of their own money on 1,040 shares at $8.
+$8.3K
1,040 sh @ $8
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $91.4K of their own money on 11,494 shares at $8.
+$91.4K
11,494 sh @ $8
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $7.8K of their own money on 1,059 shares at $7.
+$7.8K
1,059 sh @ $7
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $86.5K of their own money on 11,701 shares at $7.
+$86.5K
11,701 sh @ $7
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $21.1K of their own money on 2,795 shares at $8, growing their stake 1%.
+$21.1K
2,795 sh @ $8
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $232.8K of their own money on 30,879 shares at $8, growing their stake 1%.
+$232.8K
30,879 sh @ $8
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $16.6K of their own money on 2,296 shares at $7, growing their stake 1%.
+$16.6K
2,296 sh @ $7
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $183K of their own money on 25,364 shares at $7, growing their stake 1%.
+$183K
25,364 sh @ $7
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $1.9K of their own money on 267 shares at $7.
+$1.9K
267 sh @ $7
TRDA
Baker Bros. Advisors Lp, TRDA's 10% owner, spent $21.3K of their own money on 2,947 shares at $7.
+$21.3K
2,947 sh @ $7
Frequently asked questions
How is BAKER BROS. ADVISORS LP's win rate calculated?
We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.
Why are some buys not included in the score?
A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.
What do the 1M / 3M / 6M / 12M columns mean?
They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.
Does a high win rate mean I should copy this insider?
No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.
Where does this data come from?
Trades come from BAKER BROS. ADVISORS LP's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.